Joana Goncalves
CIK 1756991 · Chief Medical Officer · last filed 2026-05-15
Joana Goncalves is a Chief Medical Officer who has filed 43 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for ORKA, was dated May 15, 2026. Across all open-market trades the lifetime net is −$2.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.33M
2
43
-$2.81M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ORKA | Chief Medical Officer | 33,377 | $69.89 | $2.33M | -$1.87M | 8 | 2026-05-15 |
| Tvardi Therapeutics, Inc. (CARA) Delisted | CHIEF MEDICAL OFFICER | 53,365 | $15.96 | $851.7K | -$942.1K | 35 | 2024-04-09 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-15 | ORKA | Mixed | — | -$381.7K | EDGAR |
| 2026-04-15 | ORKA | Mixed | — | -$411.6K | EDGAR |
| 2026-03-17 | ORKA | Mixed | −641 | -$261.3K | EDGAR |
| 2026-02-17 | ORKA | Mixed | — | -$175.3K | EDGAR |
| 2026-01-23 | ORKA | Grant (A) | +32,500 | $0 | EDGAR |
| 2026-01-16 | ORKA | Mixed | — | -$171.5K | EDGAR |
| 2025-12-19 | ORKA | Mixed | — | -$163.1K | EDGAR |
| 2025-01-24 | ORKA | Grant (A) | — | $0 | EDGAR |
| 2024-04-09 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −2,753 | -$2.3K | EDGAR |
| 2024-03-04 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −3,293 | -$2.9K | EDGAR |